The Swiss Medtech General Assembly 2026 is a key annual gathering for stakeholders across Switzerland’s medical technology sector. Organised by Swiss Medtech, the event brings together industry leaders, member companies, policymakers, healthcare experts, and innovation partners to review developments, discuss strategic priorities, and shape the future of the Swiss medtech ecosystem.As one of the most important meetings in the national medtech calendar, the General Assembly provides a platform for governance, networking, and industry dialogue, offering participants valuable insights into regulatory updates, market trends, and innovation opportunities.Key Topics

• Strategic outlook for the Swiss medtech sector
• Regulatory and policy developments
• Industry innovation and technology trends
• Market access and international competitiveness
• Sustainability and supply chain resilience
• Collaboration between industry and healthcare systems

Who Should AttendThe assembly is designed for:

• Member companies and executives
• Medical technology manufacturers and suppliers
• Healthcare industry stakeholders
• Policy and regulatory representatives
• Investors and innovation partners
• Industry analysts and consultants

Benefits of ParticipationAttendees will gain:

• First-hand updates on industry strategy and initiatives
• Insights into the latest regulatory and market developments
• Opportunities to connect with key decision-makers
• A voice in shaping the future direction of the association

Why AttendThe Swiss Medtech General Assembly 2026 plays a vital role in strengthening collaboration, transparency, and strategic alignment across Switzerland’s medical technology community. By fostering dialogue and shared vision, the event supports innovation, competitiveness, and sustainable growth within the sector.